These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11011323)

  • 21. Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism.
    Ishimitsu T; Tsukada K; Ohta S; Inada H; Minami J; Ono H; Matsuoka H
    Am J Kidney Dis; 2004 Sep; 44(3):466-75. PubMed ID: 15332219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease.
    Low YL; Tai ES
    Mutat Res; 2007 Sep; 622(1-2):7-13. PubMed ID: 17555770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tru9 I restriction polymorphism in vitamin D receptor may cause failure of PCR amplification in Bsm I polymorphism.
    Montenegro MF
    Int J Cardiol; 2007 Jan; 114(3):414; author reply 415. PubMed ID: 16644041
    [No Abstract]   [Full Text] [Related]  

  • 24. [Genetic polymorphisms in cardiovascular diseases. The experience in the National Institute of Cardiology "Ignacio Chávez"].
    Vargas Alarcón G
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-88-93. PubMed ID: 18938704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaining insights in coronary disease genomics.
    Murray SS; Topol EJ
    J Am Coll Cardiol; 2008 Jul; 52(5):385-6. PubMed ID: 18652947
    [No Abstract]   [Full Text] [Related]  

  • 26. Epidemiological and genetic approach to cardiovascular disease.
    Tiret L
    Pathol Biol (Paris); 1998 Nov; 46(9):715-6. PubMed ID: 9885828
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.
    Ye S
    Cardiovasc Res; 2006 Feb; 69(3):636-45. PubMed ID: 16122719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What role do adrenoreceptor polymorphisms play in modifying cardiovascular responses in obstructive sleep apnoea?
    McArdle N
    Clin Sci (Lond); 2006 Jan; 110(1):89-91. PubMed ID: 16287427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.
    Carroll L; Frazer IH; Turner M; Marwick TH; Thomas R
    Arthritis Res Ther; 2007; 9(2):R39. PubMed ID: 17425804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
    Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To lyse or not to lyse: is it genetic?
    Carter AM; Grant PJ
    Ital Heart J; 2001 Sep; 2(9):652-5. PubMed ID: 11666091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease.
    Porreca E; Di Febbo C; Pintor S; Baccante G; Gatta V; Moretta V; Nisio MD; Palka C; Cuccurullo F; Stuppia L
    Int J Obes (Lond); 2006 Feb; 30(2):209-13. PubMed ID: 16261186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Cheng S; Fontecha MR; Li J; Defesche JC; Kastelein JJ
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular mortality in high-risk patients and T-786C polymorphism in promoter region of the endothelial nitric oxide synthase gene.
    Tanus-Santos JE; Casella-Filho A
    J Am Coll Cardiol; 2007 Mar; 49(11):1225-6; author reply 1226-7. PubMed ID: 17367669
    [No Abstract]   [Full Text] [Related]  

  • 35. Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.
    Kathiresan S; Yang Q; Larson MG; Camargo AL; Tofler GH; Hirschhorn JN; Gabriel SB; O'Donnell CJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1405-12. PubMed ID: 16614319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene polymorphism association studies in dialysis: cardiovascular disease.
    Rao M; Jaber BL; Balakrishnan VS;
    Semin Dial; 2005; 18(3):217-25. PubMed ID: 15934969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants predisposing to cardiovascular disease.
    Visvikis-Siest S; Marteau JB
    Curr Opin Lipidol; 2006 Apr; 17(2):139-51. PubMed ID: 16531750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large.
    Mooijaart SP; Koeijvoets KM; Sijbrands EJ; Daha MR; Westendorp RG
    Exp Gerontol; 2007 Nov; 42(11):1116-22. PubMed ID: 17869048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetics of cardiovascular diseases].
    Komajda M
    Arch Mal Coeur Vaiss; 1997 Jun; 90 Spec No 3():9-10. PubMed ID: 9295917
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic markers: progress and potential for cardiovascular disease.
    Gibbons GH; Liew CC; Goodarzi MO; Rotter JI; Hsueh WA; Siragy HM; Pratt R; Dzau VJ
    Circulation; 2004 Jun; 109(25 Suppl 1):IV47-58. PubMed ID: 15226250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.